the Management of Benign Liver Lesions

Benign liver lesions are a heterogeneous group of lesions with different cellular origins, as summarized by an international panel of experts sponsored by the World Congress of Gastroenterology in 1994,(5). Some of these lesions are of greater clinical relevance than others, and the aim of these recommendations is to

 provide a contemporary aid for the practical diagnosis and management of the more common benign lesions. These include haemangiomas, focal nodular hyperplasia (FNH), hepatocellular adenoma (HCA) and hepatocystic disease including poly-cystic liver, (4 & 6).

There is no justification to recommend histopathology of liver lesions or molecular subtyping of HCA as routine clinical practice. As evidence accumulates and methodologies improve with respect to risk and sensitivity, this may change. ⁽⁴⁾.